Lokelma fda?

Yes. Lokelma (sodium zirconium cyclosilicate, also known as ZS-9) is FDA-approved for the treatment of hyperkalemia in adults and in pediatric patients aged 5 years and older. It is a prescription potassium binder that works in the gut to exchange potassium for hydrogen and ammonium ions (not absorbed into the bloodstream).

Key points:
- Indication: treatment of hyperkalemia.
- Who can use: adults and children 5 years and older; prescription only.
- How it’s used: taken by mouth (usually as a powder mixed with water). The exact dose and duration are determined by your clinician based on your potassium level and response.
- Common side effects: edema (swelling), nausea, vomiting, constipation, abdominal pain. It can cause potassium levels to drop too low (hypokalemia) if overused or not monitored.
- Warnings/precautions: use with caution in people with GI disorders; avoid concomitant use with sorbitol-containing products due to risk of intestinal injury; monitor potassium levels and kidney function as directed.
- Where to get: prescription from a healthcare provider.

If you’re considering Lokelma or have a prescription, discuss dosing, monitoring, and potential interactions with your doctor or pharmacist. If you meant something else about FDA status or a specific question, tell me and I’ll adjust.